Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04325789 · ClinicalTrials.gov registry record · NA
Rotator Cuff Healing Using a Nanofiber Scaffold in Patients Greater Than 55 Years
A NA study of Rotator Cuff Tears and Full-thickness Rotator Cuff Tears, sponsored by Atreon Orthopedics.
- Active
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 4
- Study locations
NCT04325789: Active NA study of Rotator Cuff Tears and Full-thickness Rotator Cuff Tears, sponsored by Atreon Orthopedics.
NCT04325789 is a NA study of Rotator Cuff Tears and Full-thickness Rotator Cuff Tears that is active but no longer recruiting, run by Atreon Orthopedics. The registered enrollment target is 91 participants, below the 1,277-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04325789, a NA study of Rotator Cuff Tears and Full-thickness Rotator Cuff Tears, is active but no longer recruiting, sponsored by Atreon Orthopedics.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 4
- Study locations
Study Summary
Randomized controlled trial of patients over the age of 55 treated with and without a nanofiber scaffold during rotator cuff repair.
Primary Outcome
To determine if the use of the nanofiber scaffold changes the occurrence of postoperative rotator cuff repair (RCR) failure in patients older than 55 years
Conditions Studied
Interventions
- DEVICE nanofiber scaffold
Study Locations (4)
Indiana
- Central Indiana Orthopedics - Fishers
Michigan
- Associated Orthopedists of Detroit - Saint Clair Shores
Ohio
- The Christ Hospital & The Lindner Reseach Center at The Christ Hospital - Cincinnati
South Carolina
- Steadman Hawkins Clinic of the Carolinas - Patewood - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2020-06-29 |
| Est. Completion | 2025-03-15 |
| Phase | NA |
What the registry record for NCT04325789 still lists
NCT04325789 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,277-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Rotator Cuff Tears appearing as the primary indexed condition, and to 1 intervention - of which nanofiber scaffold is the first listed.
NCT04325789 reports a single indexed study location in Indiana, Michigan, Ohio.
Frequently Asked Questions
What is clinical trial NCT04325789 about?
NCT04325789 is a clinical study titled "Rotator Cuff Healing Using a Nanofiber Scaffold in Patients Greater Than 55 Years". Randomized controlled trial of patients over the age of 55 treated with and without a nanofiber scaffold during rotator cuff repair.
What is the current status of trial NCT04325789?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 91 participants. The study started on 2020-06-29. Estimated completion is 2025-03-15.
What conditions does trial NCT04325789 study?
This clinical trial studies the following conditions: Rotator Cuff Tears, Full-thickness Rotator Cuff Tears.
What interventions are being tested in trial NCT04325789?
The interventions under investigation include: nanofiber scaffold (DEVICE).
Who is sponsoring clinical trial NCT04325789?
This trial is sponsored by Atreon Orthopedics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04325789 being conducted?
This trial has 4 study locations across Indiana, Michigan, Ohio, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tears
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04325789's enrollment target sits among peer trials
91 10th of 20 higher than 11 of 20 other Rotator Cuff Tears trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rotator Cuff Tears trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
FiberLocker® System Augmentation of Rotator Cuff Repairs
RECRUITING · NA
-
InSpace Accelerated Rehabilitation Study
RECRUITING · NA
-
Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair
RECRUITING · NA
-
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
RECRUITING · NA
-
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
RECRUITING · NA
-
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI